Jim Halley Articles

Transferring a patient from the emergency area into the ICU

Oct 30, 2023 by Jim Halley

3 Green Flags and 1 Red Flag for Medical Properties Trust

The beleaguered healthcare REIT has made itself a less risky stock.

Oct 30, 2023 by Jim Halley

5 Reasons Beam Therapeutics Remains a Risky Stock

Shares of the gene-editing biotech might not have hit rock bottom yet.

Group of medical practitioners having a seminar in board room

Oct 26, 2023 by Jim Halley

Roche, Lilly or Pfizer: Who's the Winner in IBD Wars?

The three companies are spending big on IBD therapies.

Oct 26, 2023 by Jim Halley

2 Green Flags and 1 Red Flag for Novartis Stock

The Swiss pharmaceutical company just posted strong Q3 numbers and is going through some big changes.

Oct 25, 2023 by Jim Halley

3 Pharma Stocks That Are Screaming Buys in October

Each company delivers an above-average dividend and revenue growth.

Oct 24, 2023 by Jim Halley

3 Dental Supply Stocks You Can Sink Your Teeth Into

Long-term trends and margin improvements are driving growth for dental supply companies.

Oct 21, 2023 by Jim Halley

3 Stocks Cathie Wood Is Buying That Should Be on Your List Too

The three companies are positioned to benefit from red-hot trends.

Oct 20, 2023 by Jim Halley

Which Is the Better Long-Term Hold for Investors: Pfizer or Roche?

The venerable pharmaceutical companies' shares have slumped this year.

Oct 19, 2023 by Jim Halley

3 Things About Bristol Myers Squibb That Smart Investors Know

The stock is down this year, but will its struggles fade into the rearview mirror?

Oct 18, 2023 by Jim Halley

Which Is the Better Cannabis Growth Stock for You: Cresco Labs or TerrAscend?

Cannabis stocks are back in style, but is either one of these multi-state operators a long-term buy?

Oct 18, 2023 by Jim Halley

4 Ways to Grow $100,000 Into $1 Million for Retirement

Investing for big-time growth doesn't have to be risky.

Oct 17, 2023 by Jim Halley

3 Under-the-Radar Biotech Stocks to Buy in 2023

These three lesser-known biotech companies are profitable and growing revenue.

pharmacy pharmacist drug medicine prescription (2)

Oct 13, 2023 by Jim Halley

Why Shares of Revolution Medicines Were Popping on Friday

The company released positive phase 1/1b trial data on two cancer therapies.

Senior patient looking through window at hospital

Oct 13, 2023 by Jim Halley

Why Shares of Harmony Bioscience Are Falling on Friday

The company reported underwhelming phase 3 trial results for Pitolisant to treat idiopathic hypersomnia.

using a stethoscope listen to the heartbeat of patient

Oct 13, 2023 by Jim Halley

Why Shares of T2 Biosystems Are Falling Friday

A revenue drop and a reverse stock split worried investors.

Oct 13, 2023 by Jim Halley

2 Robinhood Stocks With Market-Beating Potential

These diamonds in the rough won't stay down.

Oct 12, 2023 by Jim Halley

Why Shares of Insulet Dropped This Week

Positive news regarding diabetes therapy Ozempic worried investors.

Oct 12, 2023 by Jim Halley

Why Akero Therapeutics Shares Are Slumping This Week

Akero's lead therapy fell short of its goals in a phase 2b trial to treat NASH.

Oct 12, 2023 by Jim Halley

Why Shares of ProKidney Were Dropping Thursday

Two factors led to the stock's slide on Thursday.

Oct 11, 2023 by Jim Halley

Why Shares of Ardelyx Were Down Wednesday

The company's hopes for approval of a drug to treat chronic kidney disease took a hit.

Jim Halley

Recent Articles by Jim Halley

3 Green Flags and 1 Red Flag for Medical Properties Trust

5 Reasons Beam Therapeutics Remains a Risky Stock

Roche, Lilly or Pfizer: Who's the Winner in IBD Wars?

2 Green Flags and 1 Red Flag for Novartis Stock

3 Pharma Stocks That Are Screaming Buys in October

3 Dental Supply Stocks You Can Sink Your Teeth Into

3 Stocks Cathie Wood Is Buying That Should Be on Your List Too

Which Is the Better Long-Term Hold for Investors: Pfizer or Roche?

3 Things About Bristol Myers Squibb That Smart Investors Know

Which Is the Better Cannabis Growth Stock for You: Cresco Labs or TerrAscend?

4 Ways to Grow $100,000 Into $1 Million for Retirement

3 Under-the-Radar Biotech Stocks to Buy in 2023

Why Shares of Revolution Medicines Were Popping on Friday

Why Shares of Harmony Bioscience Are Falling on Friday

Why Shares of T2 Biosystems Are Falling Friday

2 Robinhood Stocks With Market-Beating Potential

Why Shares of Insulet Dropped This Week

Why Akero Therapeutics Shares Are Slumping This Week

Why Shares of ProKidney Were Dropping Thursday

Why Shares of Ardelyx Were Down Wednesday

Premium Investing Services